Are you looking for some exchange traded funds (ETFs) to add to your portfolio? If you are, it could be worth taking a closer look at the three ETFs listed below.

These ETFs include some of the highest quality companies on offer globally across the banking, healthcare, and tech sectors. Here’s what you need to know about them right now:

BetaShares Asia Technology Tigers ETF (ASX: ASIA)

If you’re wanting to gain exposure to the growing Asian economy, then the BetaShares Asia Technology Tigers ETF could be a way to do this. This ETF gives investors access to a number of the most promising tech shares in the Asian market. These are the Apples, Googles, and Amazons of Asia such as e-commerce leaders Alibaba and JD.com, search engine company Baidu, and WeChat owner Tencent.

iShares Global Healthcare ETF (ASX: IXJ)

Another ETF to look at is the iShares Global Healthcare ETF. This ETF provides investors with easy access to many of the biggest and brightest healthcare companies in the world. This includes Australia’s CSL Ltd (ASX: CSL) and Ramsay Health Care Limited (ASX: RHC), as well as a host of global giant such as Astra Zeneca, Johnson & Johnson, Moderna, Novartis, Pfizer, and Sanofi.

VanEck Vectors Australian Banks ETF (ASX: MVB)

Finally, if you’re wanting exposure to the banking sector, then you might want to look at the VanEck Vectors Australian Banks ETF. This ETF allows you to own a slice of all the big four banks, the regionals, and investment bank Macquarie Group Ltd (ASX: MQG) through a single investment. As these bank shares are traditionally big dividend payers, this ETF could prove to be a good source of income for investors.

The post 3 top ETFs for ASX investors to look at this month appeared first on The Motley Fool Australia.

More reading

• Are these 2 ASX tech shares good buys in February?
• 3 of the best ETFs for ASX investors this month
• 3 high quality ETFs for ASX investors in February
• 2 top international ETFs for ASX investors
• 2 excellent ETFs for ASX investors to buy this month

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BetaShares Asia Technology Tigers ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/oNPdn7O

Key points

• ASX dividend shares can be very effective at boosting investment income
• Adairs is a retail stock that sells homewares and furniture. Rolling out more stores and increasing online sales are key strategies
• GQG is steadily growing its FUM and has committed to a fairly high dividend payout ratio

---

ASX dividend shares could be an excellent place to look for income for investors wanting to boost their investment yield.

When a share price drops, it can have the added bonus of increasing the prospective dividend yield for investors that buy shares.

The recent ASX share market correction could make these two options very attractive for dividends

Adairs Ltd (ASX: ADH)

Adairs is a retail stock that sells a wide range of furniture and furnishings. It has the Adairs network of stores, but it also has online furniture business Mocka, and also Focus on Furniture after making an acquisition.

The business is working hard at ensuring customers can buy however they want to – online or in-store. It has recently invested in a new national distribution centre which is expected to save costs as well as being able to ensure it can fulfil orders faster and provided stores with better stock flow.

Another of the ASX dividend share’s key profit-boosting tactics is to open more large-format stores. They are substantially more profitable than smaller ones as it allows the company to sell more of its products in a single location. An upsized store is approximately 60% more profitable according to Adairs.

With Focus, Adairs also has plans to roll-out a national store network, expand its product offerings and grow online sales. It also increases Adairs’ exposure to the ‘bulky furniture’ category.

It’s currently rated as a buy by Morgans with a projected grossed-up dividend yield of 8.3% in FY22 and 11.4% in FY23.

GQG Partners Inc (ASX: GQG)

GQG is one of the largest fund managers on the ASX. It is a US-based fund manager, though it does have ambitions of growing funds under management in different places like Australia.

This fund manager offers a few different investment strategies such as US share funds, international share funds and dividend share funds.

One of the main ways that GQG Partners, and any fund manager, can grow profit, is by growing funds under management (FUM). On 30 September 2021, the FUM was US$85.8 billion. By 31 December 2021, FUM had grown to be $91.2 billion. In the three months to December 2021, quarterly net inflows were US$3 billion.

The ASX dividend share seeing business momentum across multiple geographies and channels. Its recently launched strategies and products continue to achieve “strong adoption”.

Not only are GQG’s management fees lower than many active fund managers, but its management fees comprise the vast majority of its net revenue, as opposed to performance fees.

The management team is “highly aligned” with all shareholders as the largest shareholders in GQG. Management are “acutely focused on and committed” to GQG’s future.

It’s currently rated as a buy by Morgans, with a price target of $2.40. The broker thinks it has compelling long-term potential with solid earnings.

The broker projects that GQG will pay a dividend yield of 7.4% in FY22 and 8.6% in FY23.

The post Got money to invest for dividends? Here are 2 ASX shares that could be buys appeared first on The Motley Fool Australia.

More reading

• Could this be the biggest issue faced by ASX retail shares heading into earnings season?
• 2 ASX dividend shares with grossed-up yields over 8% right now
• 2 buy-rated ASX dividend shares for February
• Are these 2 ASX dividend shares buys in February 2022?
• Why analysts are bullish on these 2 ASX dividend shares

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended ADAIRS FPO. The Motley Fool Australia owns and has recommended ADAIRS FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/RTVWU1P

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that investors might want to hear about are summarised below. Here’s why top brokers think investors ought to sell these shares next week:

AMP Ltd (ASX: AMP)

According to a note out of UBS, its analysts have retained their sell rating and 90 cents price target on this embattled financial services company’s shares. UBS notes that consensus estimates for AMP’s results have been lowered. Despite this, it feels the market continues to expect too much from the struggling company and is forecasting a result well short of expectations. The AMP share price was trading at 96 cents on Friday.

ARB Corporation Limited (ASX: ARB)

A note out of Credit Suisse reveals that its analysts have retained their underperform rating but lifted their price target on this 4×4 parts manufacturer’s shares to $40.60. While Credit Suisse was pleasantly surprised to see ARB outperform its estimates during the first half of FY 2022, it isn’t enough for a change of rating. Credit Suisse still believes ARB’s shares are overvalued at the current level and has concerns that its margins are unsustainable. The ARB share price was fetching $44.33 at Friday’s close.

Commonwealth Bank of Australia (ASX: CBA)

Analysts at Morgans have retained their reduce rating and $74.00 price target on this banking giant’s shares. According to the note, the broker continues to believe that CBA’s shares are overvalued at the current level and don’t deserve to trade at such a premium to the rest of the big four banks. Morgans is expecting first half cash earnings of $4.320 billion and a fully franked interim dividend of $1.74 per share. CBA will no doubt need to deliver something significantly better than this to change Morgans’ mind about its shares. The CBA share price was trading at $94.10 at Friday’s close.

The post Top brokers name 3 ASX shares to sell next week appeared first on The Motley Fool Australia.

More reading

• Own CBA (ASX:CBA) shares? Here’s how the bank is investing in BNPL-style home loans
• Hunting for ASX shares? Experts say to avoid this sector in 2022
• What can the Westpac results tell us about the outlook for ASX 200 bank shares?
• Top brokers name 3 ASX shares to sell today
• Why these brokers think that the CBA (ASX:CBA) share price is a sell

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ARB Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/HDmVk7U

If you have room for a share or two in your portfolio then take a look at the excellent ASX 200 shares listed below.

Analysts have recently tipped these shares as ones to buy. Here’s what you need to know:

CSL Limited (ASX: CSL)

The first ASX 200 share for investors to look at is CSL. It is one of the world’s leading biotechnology companies and the name behind the CSL Behring and Seqirus businesses. Both are leaders in their respective fields of plasma therapies and vaccines.

In addition, the company is in the process of making a major acquisition. It is aiming to acquire Vifor Pharma, which is a leader in iron deficiency, nephrology and cardio-renal therapies, for $16.4 billion.

Citi is a fan of CSL. It recently upgraded the company’s shares to a buy rating with a $340.00 price target.

It was pleased with the acquisition of Vifor, commenting: “Because of the large difference in the earnings multiples of both companies and the low cost of debt, we expect the transaction to be double digit NPATA accretive (although ROIC dilutive). The key positive from the transaction is that it expands the CSL late stage R&D pipeline, which we have noted for some time was limited for a company the size of CSL.”

Wesfarmers Ltd (ASX: WES)

Another ASX 200 share to look at is Wesfarmers. It is the conglomerate behind several popular retail brands such as Bunnings and Kmart. It also has a diverse portfolio of industrial businesses.

While FY 2022 has been a tough year because of lockdowns and other COVID headwinds, the company looks well-placed for the future thanks to its strong brands, diverse operations, and balance sheet strength. The latter looks set to support M&A activity and the potential expansion into the healthcare sector.

Morgans is very positive on the company. It currently has an add rating and $60.80 price target on its shares.

The broker recently commented: “The company is run by a highly regarded management team and the balance sheet is healthy. While COVID-related staff shortages are proving to be a challenge, the core Bunnings division (>60% of group EBIT) remains a solid performer as consumers continue to invest in their homes. We see the recent pullback in the share price as a good entry point for longer term investors.”

The post 2 fantastic ASX 200 shares to buy right now appeared first on The Motley Fool Australia.

More reading

• Could this be the biggest issue faced by ASX retail shares heading into earnings season?
• Can the CSL (ASX:CSL) share price crack the $300 mark in 2022?
• Do any ASX lithium shares pay dividends?
• Morgans names 4 more of the best ASX shares to buy in February
• The Wesfarmers (ASX:WES) share price is 20% off its all-time high. Is it a buy?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia owns and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/PZsw6yp